Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Torimoto, Keiichi ^a   Okada, Yosuke ^a   Mori, Hiroko ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Atherosclerosis; Continuous glucose monitoring (CGM); Endothelium; Glucose; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIABETES CONTROL; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPEREMIA; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; REACTIVE HYPEREMIA INDEX; TONOMETER; TONOMETRY; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84871677195     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-1     Document Type: Article

References (37)

1. Haffner SM, Lehto S, Rönnemaa Pyörälthomampersa K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and non diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444. 10.2337/diacare.16.2.434, 8432214.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979, 241:2035-2038. 10.1001/jama.1979.03290450033020, 430798.
4. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 1987, 257:949-952. 10.1001/jama.1987.03390070069025, 3806877.
5. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke 1996, 27:1479-1486. 10.1161/01.STR.27.9.1479, 8784116.
6. ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
7. Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 24:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
8. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor?. Diabetes Metab Res Rev 2008, 24:353-363. 10.1002/dmrr.865, 18461635.
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126. 10.1056/NEJM199901143400207, 9887164.
10. Xu J, Zou MH. Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 2009, 120:1266-1286. 10.1161/CIRCULATIONAHA.108.835223, 2910587, 19786641.
11. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008, 57:1349-1354. 10.2337/db08-0063, 18299315.
12. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 2003, 146:168-174. 10.1016/S0002-8703(03)00094-2, 12851627.
13. Celermajer DS. Reliable endothelial function testing: at our fingertips?. Circulation 2008, 117:2428-2430. 10.1161/CIRCULATIONAHA.108.775155, 18474821.
14. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970, 19:644-655.
15. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003, 52:2790-2794. 10.2337/diabetes.52.11.2790, 14578298.
16. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 2004, 44:2137-2141. 10.1016/j.jacc.2004.08.062, 15582310.
17. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Invest 2010, 1:212-228. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.
18. Rubinshtein R, Kuvin JT, Soffler M, Lennon RJ, Lavi S, Nelson RE, Pumper GM, Lerman LO, Lerman A. Assessment of endothelial function by noninvasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010, 31:1142-1148. 10.1093/eurheartj/ehq010, 20181680.
19. Hamburg NM, Palmisano J, Larson MG, Sullivan LM, Lehman BT, Vasan RS, Levy D, Mitchell GF, Vita JA, Benjamin EJ. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension 2011, 57:390-396. 10.1161/HYPERTENSIONAHA.110.160812, 3049726, 21263120.
20. Schnabel RB, Schulz A, Wild PS, Sinning CR, Wilde S, Eleftheriadis M, Herkenhoff S, Zeller T, Lubos E, Lackner KJ, Warnholtz A, Gori T, Blankenberg S, Münzel T. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 2011, 4:371-380. 10.1161/CIRCIMAGING.110.961557, 21551420.
21. Buscemi S, Re A, Batsis JA, Arnone M, Mattina A, Cerasola G, Verga S. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Diabet Med 2010, 27:872-878. 10.1111/j.1464-5491.2010.03059.x, 20653743.
22. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006, 295:1681-1687. 10.1001/jama.295.14.1681, 16609090.
23. Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012, 11. [Epub ahead of print].
24. Monnier L, Colette C, Owens DR. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept. Diabetes Metab Res Rev 2009, 25:393-402. 10.1002/dmrr.962, 19437415.
25. Suzuki K, Watanabe K, Futami-Suda S, Yano H, Motoyama M, Matsumura N, Igari Y, Suzuki T, Nakano H, Oba K. The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance. Cardiovasc Diabetol 2012, 11:98. 10.1186/1475-2840-11-98, 3471039, 22891922.
26. Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS, Laatikainen T, Tuomilehto J, Pyörälä K, Qiao Q. DECODE Finnish and Swedish Study Investigators: Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc Diabetol 2012, 11:76. 10.1186/1475-2840-11-76, 3423058, 22731255.
27. Matsuoka H. Endothelial dysfunction associated with oxidative stress in human. Diabetes Res Clin Pract 2001, 54(suppl 2):S65-72.
28. Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003, 52:1256-1264. 10.2337/diabetes.52.5.1256, 12716761.
29. Cosentino F, Hishikawa K, Katusic Z, Lüscher TF. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96:25-28. 10.1161/01.CIR.96.1.25, 9236411.
30. Lin KY, Ito A, Asagami T, Tsao PS, Adimoolam S, Kimoto M, Tsuji H, Reaven GM, Cooke JP. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002, 106:987-992. 10.1161/01.CIR.0000027109.14149.67, 12186805.
31. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol 2011, 10:19. 10.1186/1475-2840-10-19, 3056765, 21349201.
32. Buscemi S, Verga S, Cottone S, Azzolina V, Buscemi B, Gioia D, Cerasola G. Glycaemic variability and inflammation in subjects with metabolic syndrome. Acta Diabetol 2009, 46:55-61. 10.1007/s00592-008-0061-8, 18818862.
33. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, Frontoni S. Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 2011, 34:1605-1609. 10.2337/dc11-0034, 3120198, 21610126.
34. Peña AS, Couper JJ, Harrington J, Gent R, Fairchild J, Tham E, Baghurst P. Hypoglycemia, but not glucose variability, relates to vascular function in children with type 1 diabetes. Diabetes Technol Ther 2012, 14:457-62. 10.1089/dia.2011.0229, 22313018.
35. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010, 33:1389-1394. 10.2337/dc09-2082, 2875462, 20508232.
36. Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, Mitchell GF, Sheffy J, Vita JA, Benjamin EJ. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008, 117:2467-2474. 10.1161/CIRCULATIONAHA.107.748574, 2734141, 18458169.
37. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008, 31:1473-1478. 10.2337/dc08-0545, 2742903, 18540046.